Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human LIN-28A His Protein
SDP

Catalog No. NBP130275 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP130275 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP130275 Supplier Novus Biologicals™ Supplier No. NBP130275
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results.

A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 42-209 of Human LIN-28A The Recombinant Human LIN-28A Protein is derived from E. coli. The Recombinant Human LIN-28A Protein has been validated for the following applications: SDS-Page.

Specifications

Accession Number Q9H9Z2
Concentration 0.5 mg/mL
For Use With (Application) SDS-PAGE
Formulation 20 mM Tris-HCl buffer (pH 8.0), 10% glycerol, 0.1 M NaCl, 0.1 PMSF
Gene ID (Entrez) 79727
Molecular Weight (g/mol) M.W. (theoretical): 21.1 kDa
Name LIN-28A Protein
Purification Method Protein
Quantity 0.05 mg
Source E. Coli
Immunogen Lin28, 42-209 aa, Human, His-tag, E.coli (NP_078950).
Storage Requirements Store at 4 C short term. Aliquot and store (at -20 C long term. Avoid freeze-thaw cycles.)
Regulatory Status RUO
Gene Symbol LIN28A
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Research Category Epigenetics, Neuroscience, Stem Cell Markers, Stem Cells
Purity or Quality Grade >90%, by SDS-PAGE
Protein LIN-28 A
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.